Cutaneous T-cell lymphomas-An update 2021.
Kempf W, Mitteldorf C.
Hematol Oncol. 2021 Jun;39 Suppl 1:46-51. doi: 10.1002/hon.2850.
Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Hristov AC, Tejasvi T, Wilcox RA.
Am J Hematol. 2023 Jan;98(1):193-209. doi: 10.1002/ajh.26760. Epub 2022 Oct 20.
Mycosis fungoides and Sezary syndrome: 2019 update on diagnosis, risk-stratification, and management.
Hristov AC, Tejasvi T, Wilcox RA.
Am J Hematol. 2019 Sep;94(9):1027-1041. doi: 10.1002/ajh.25577. Epub 2019 Jul 31.
Tumor stage mycosis fungoides: a single-center study on clinicopathologic features, treatments, and patient outcome.
Patrawala SA, Broussard KC, Wang L, Zic JA.
Dermatol Online J. 2016 May 15;22(5):13030/qt1q15b903.
Tumor Stage Mycosis Fungoides in a Child.
Dulmage BO, Villaseñor-Park J, Ho J, Geskin LJ, Grandinetti LM.
Pediatr Dermatol. 2015 Jul-Aug;32(4):e156-8. doi: 10.1111/pde.12570. Epub 2015 Apr 17.
Leser-Trelat Sign in Tumor-Stage Mycosis Fungoides.
Rowe B, Shevchenko A, Yosipovitch G.
Dermatol Online J. 2016 Apr 18;22(4):13030/qt76c2m5jr.
The Impact of Primary Tumor Site on Survival in Mycosis Fungoides.
Go CC, Zhong A, Linaburg T, Briceño CA.
Cutis. 2024 Apr;113(4):177-182. doi: 10.12788/cutis.0991.
Transcriptomic changes during stage progression of mycosis fungoides.
Xiao MZX, Hennessey D, Iyer A, O'Keefe S, Zhang F, Sivanand A, Gniadecki R.
Br J Dermatol. 2022 Mar;186(3):520-531. doi: 10.1111/bjd.20760. Epub 2021 Nov 24.
Mycosis fungoides.
Zinzani PL, Ferreri AJ, Cerroni L.
Crit Rev Oncol Hematol. 2008 Feb;65(2):172-82. doi: 10.1016/j.critrevonc.2007.08.004. Epub 2007 Oct 22.
Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides.
Dong Z, Zhu X, Li Y, Gan L, Chen H, Zhang W, Sun J.
Medicine (Baltimore). 2018 May;97(21):e10871. doi: 10.1097/MD.0000000000010871.
